The who risk factor index, risk of vertebral fractures and reduction in fracture risk with alendronate: The fracture invervention trial

被引：0
|
作者：
Cummings, S. R.
Palermo, L.
Ensrud, K. E.
Schousboe, J. T.
Johansson, H.
Kanis, J. A.
机构：
[1] Univ Calif San Francisco, San Francisco Coordinating Ctr, CPMC Res Inst, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Minnesota, Minneapolis, MN 55455 USA
[4] Parc Nicollet Hlth Serv, Minneapolis, MN USA
[5] WHO Collaborating Ctr Metab Bone Dis, Sheffield, S Yorkshire, England
来源：
CALCIFIED TISSUE INTERNATIONAL | 2007年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [1] Alendronate and vertebral fracture risk
    Mikhail, N
    Cope, D
    [J]. MAYO CLINIC PROCEEDINGS, 2005, 80 (09) : 1236 - 1236
  • [2] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
    Black, DM
    Cummings, SR
    Karpf, DB
    Cauley, JA
    Thompson, DE
    Nevitt, MC
    Bauer, DC
    Genant, HK
    Haskell, WL
    Marcus, R
    Ott, SM
    Torner, JC
    Quandt, SA
    Reiss, TF
    Ensrud, KE
    [J]. LANCET, 1996, 348 (9041): : 1535 - 1541
  • [3] Alendronate and vertebral fracture risk - Reply
    Quandt, SA
    Thompson, DE
    Schneider, DL
    Nevitt, MC
    [J]. MAYO CLINIC PROCEEDINGS, 2005, 80 (09) : 1238 - +
  • [4] Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial
    Black, DM
    Thompson, DE
    Bauer, DC
    Ensrud, K
    Musliner, T
    Hochberg, MC
    Nevitt, MC
    Suryawanshi, S
    Cummings, SR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11): : 4118 - 4124
  • [5] FRAX and Risk of Vertebral Fractures: The Fracture Intervention Trial
    Donaldson, Meghan G.
    Palermo, Lisa
    Schousboe, John T.
    Ensrud, Kristine E.
    Hochberg, Marc C.
    Cummings, Steven R.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (11) : 1793 - 1799
  • [6] Alendronate reduces the risk of vertebral and clinical fractures in women with existing vertebral fractures: Preliminary results of the Fracture Intervention Trial
    Black, DM
    Cummings, SR
    Karpf, DB
    Cauley, J
    Ensrud, K
    Genant, HK
    Haskell, W
    Marcus, R
    Nevitt, MC
    Ott, SM
    Quandt, SA
    Torner, JC
    Thompson, D
    [J]. OSTEOPOROSIS 1996, 1996, 1118 : 315 - 319
  • [7] Alendronate reduces risk of vertebral and clinical fractures in women with existing vertebral fractures: Results of the fracture intervention trial.
    Black, DM
    Cummings, SR
    Thompson, D
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : P242 - P242
  • [8] Alendronate reduces the risk of vertebral and hip fractures: Final results of the fracture intervention trial.
    Hochberg, MC
    Cummings, SR
    Ensrud, KE
    Torner, JC
    Quandt, S
    Black, DM
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 582 - 582
  • [9] Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial
    Cummings, SR
    Black, DM
    Thompson, DE
    Applegate, WB
    Barrett-Connor, E
    Musliner, TA
    Palermo, L
    Prineas, R
    Rubin, SM
    Scott, JC
    Vogt, T
    Wallace, R
    Yates, AJ
    LaCroix, AZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24): : 2077 - 2082
  • [10] Assessing vertebral fracture risk using biomechanical principles: Fracture risk index
    Duan, Y
    Duboeuf, F
    Munoz, F
    Turner, CH
    Delmas, PD
    Seeman, E
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S5 - S5
12345